50 Best Anticholinergic Ad Images in 2020 - BigSpy

U.S. Food and Drug Administration
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; n
COPD Treatment | TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol)
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; n
GSKPro for Healthcare Professionals
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2020 GSK or licensor. FVUBNNR190031 January 2020 Produced in USA.
COPD Treatment | TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol)
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2019 GSK or licensor. FVUBNNR190033 December 2019 Produced in USA.
COPD Treatment | TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol)
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2019 GSK or licensor. FVUBNNR190028 December 2019 Produced in USA.
COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Prescribing Info: http://bit.ly/2zUiw6Q. Prescription ANORO is used long term to treat COPD, including chronic bronchitis, emphysema, or both. ANORO is not used to relieve sudden symptoms of COPD, won't replace a rescue inhaler, and is not for asthma. IMPORTANT SAFETY INFORMATION • Do not use ANORO to treat sudden symptoms of chronic obstructive pulmonary disease (COPD). Always have a rescue inhaler with you to treat sudden symptoms. • Do not use ANORO if you have a severe allergy to milk proteins or are allergic to any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. • Do not use ANORO if you have asthma. • Do not use ANORO more often than prescribed. • Do not take ANORO with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need to use your rescue inhaler more often than usual, or if your rescue inhaler does not work as well to relieve your symptoms. • ANORO can cause serious side effects, including: − COPD symptoms that get worse over time. If this happens, do not increase your dose of ANORO; instead, call your healthcare provider. − symptoms of using too much of a LABA medicine, including: chest pain; increased blood pressure; fast or irregular heartbeat; headache; tremor; nervousness. − sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; swelling of your face, mouth, and tongue; hives; breathing problems. − effects on heart: increased blood pressure; chest pain; a fast or irregular heartbeat, awareness of heartbeat. − effects on nervous system: tremor; nervousness. − new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. − urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. − changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium. • Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Patient Information, for ANORO at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Sponsored by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed by GSK. ©2019 GSK or licensor. UCVOGM190014 November 2019 Produced in USA.
COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Prescribing Info: http://bit.ly/2zUiw6Q. Prescription ANORO is used long term to treat COPD, including chronic bronchitis, emphysema, or both. ANORO is not used to relieve sudden symptoms of COPD, won't replace a rescue inhaler, and is not for asthma. IMPORTANT SAFETY INFORMATION • Do not use ANORO to treat sudden symptoms of chronic obstructive pulmonary disease (COPD). Always have a rescue inhaler with you to treat sudden symptoms. • Do not use ANORO if you have a severe allergy to milk proteins or are allergic to any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. • Do not use ANORO if you have asthma. • Do not use ANORO more often than prescribed. • Do not take ANORO with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need to use your rescue inhaler more often than usual, or if your rescue inhaler does not work as well to relieve your symptoms. • ANORO can cause serious side effects, including: − COPD symptoms that get worse over time. If this happens, do not increase your dose of ANORO; instead, call your healthcare provider. − symptoms of using too much of a LABA medicine, including: chest pain; increased blood pressure; fast or irregular heartbeat; headache; tremor; nervousness. − sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; swelling of your face, mouth, and tongue; hives; breathing problems. − effects on heart: increased blood pressure; chest pain; a fast or irregular heartbeat, awareness of heartbeat. − effects on nervous system: tremor; nervousness. − new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. − urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. − changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium. • Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Patient Information, for ANORO at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Sponsored by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed by GSK. ©2019 GSK or licensor. UCVOGM190016 November 2019 Produced in USA.
COPD Treatment | TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol)
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2019 GSK or licensor. FVUBNNR190032 December 2019 Produced in USA.
COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Prescribing Info: http://bit.ly/2zUiw6Q. Prescription ANORO is used long term to treat COPD, including chronic bronchitis, emphysema, or both. ANORO is not used to relieve sudden symptoms of COPD, won't replace a rescue inhaler, and is not for asthma. IMPORTANT SAFETY INFORMATION • Do not use ANORO to treat sudden symptoms of chronic obstructive pulmonary disease (COPD). Always have a rescue inhaler with you to treat sudden symptoms. • Do not use ANORO if you have a severe allergy to milk proteins or are allergic to any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. • Do not use ANORO if you have asthma. • Do not use ANORO more often than prescribed. • Do not take ANORO with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need to use your rescue inhaler more often than usual, or if your rescue inhaler does not work as well to relieve your symptoms. • ANORO can cause serious side effects, including: − COPD symptoms that get worse over time. If this happens, do not increase your dose of ANORO; instead, call your healthcare provider. − symptoms of using too much of a LABA medicine, including: chest pain; increased blood pressure; fast or irregular heartbeat; headache; tremor; nervousness. − sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; swelling of your face, mouth, and tongue; hives; breathing problems. − effects on heart: increased blood pressure; chest pain; a fast or irregular heartbeat, awareness of heartbeat. − effects on nervous system: tremor; nervousness. − new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. − urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. − changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium. • Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Patient Information, for ANORO at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Sponsored by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed by GSK. ©2019 GSK or licensor. UCVOGM190015 November 2019 Produced in USA.
COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Prescribing Info: http://bit.ly/2zUiw6Q. Prescription ANORO is used long term to treat COPD, including chronic bronchitis, emphysema, or both. ANORO is not used to relieve sudden symptoms of COPD, won't replace a rescue inhaler, and is not for asthma. IMPORTANT SAFETY INFORMATION • Do not use ANORO to treat sudden symptoms of chronic obstructive pulmonary disease (COPD). Always have a rescue inhaler with you to treat sudden symptoms. • Do not use ANORO if you have a severe allergy to milk proteins or are allergic to any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. • Do not use ANORO if you have asthma. • Do not use ANORO more often than prescribed. • Do not take ANORO with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need to use your rescue inhaler more often than usual, or if your rescue inhaler does not work as well to relieve your symptoms. • ANORO can cause serious side effects, including: − COPD symptoms that get worse over time. If this happens, do not increase your dose of ANORO; instead, call your healthcare provider. − symptoms of using too much of a LABA medicine, including: chest pain; increased blood pressure; fast or irregular heartbeat; headache; tremor; nervousness. − sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; swelling of your face, mouth, and tongue; hives; breathing problems. − effects on heart: increased blood pressure; chest pain; a fast or irregular heartbeat, awareness of heartbeat. − effects on nervous system: tremor; nervousness. − new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. − urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. − changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium. • Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Patient Information, for ANORO at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Sponsored by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed by GSK. ©2019 GSK or licensor. UCVOGM190017 November 2019 Produced in USA.
COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Prescribing Info: http://bit.ly/2zUiw6Q. Prescription ANORO is used long term to treat COPD, including chronic bronchitis, emphysema, or both. ANORO is not used to relieve sudden symptoms of COPD, won't replace a rescue inhaler, and is not for asthma. IMPORTANT SAFETY INFORMATION • Do not use ANORO to treat sudden symptoms of chronic obstructive pulmonary disease (COPD). Always have a rescue inhaler with you to treat sudden symptoms. • Do not use ANORO if you have a severe allergy to milk proteins or are allergic to any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. • Do not use ANORO if you have asthma. • Do not use ANORO more often than prescribed. • Do not take ANORO with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need to use your rescue inhaler more often than usual, or if your rescue inhaler does not work as well to relieve your symptoms. • ANORO can cause serious side effects, including: − COPD symptoms that get worse over time. If this happens, do not increase your dose of ANORO; instead, call your healthcare provider. − symptoms of using too much of a LABA medicine, including: chest pain; increased blood pressure; fast or irregular heartbeat; headache; tremor; nervousness. − sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; swelling of your face, mouth, and tongue; hives; breathing problems. − effects on heart: increased blood pressure; chest pain; a fast or irregular heartbeat, awareness of heartbeat. − effects on nervous system: tremor; nervousness. − new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. − urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. − changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium. • Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Patient Information, for ANORO at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Sponsored by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed by GSK. ©2019 GSK or licensor. UCVOGM190016 November 2019 Produced in USA.
GSKPro for Healthcare Professionals
Prescribing Info: http://bit.ly/2zUiw6Q. Prescription ANORO is used long term to treat COPD, including chronic bronchitis, emphysema, or both. ANORO is not used to relieve sudden symptoms of COPD, won't replace a rescue inhaler, and is not for asthma. IMPORTANT SAFETY INFORMATION • Do not use ANORO to treat sudden symptoms of chronic obstructive pulmonary disease (COPD). Always have a rescue inhaler with you to treat sudden symptoms. • Do not use ANORO if you have a severe allergy to milk proteins or are allergic to any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. • Do not use ANORO if you have asthma. • Do not use ANORO more often than prescribed. • Do not take ANORO with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need to use your rescue inhaler more often than usual, or if your rescue inhaler does not work as well to relieve your symptoms. • ANORO can cause serious side effects, including: − COPD symptoms that get worse over time. If this happens, do not increase your dose of ANORO; instead, call your healthcare provider. − symptoms of using too much of a LABA medicine, including: chest pain; increased blood pressure; fast or irregular heartbeat; headache; tremor; nervousness. − sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; swelling of your face, mouth, and tongue; hives; breathing problems. − effects on heart: increased blood pressure; chest pain; a fast or irregular heartbeat, awareness of heartbeat. − effects on nervous system: tremor; nervousness. − new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. − urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. − changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium. • Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Patient Information, for ANORO at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Sponsored by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed by GSK. ©2019 GSK or licensor. UCVOGM190014 November 2019 Produced in USA.
COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Prescribing Info: http://bit.ly/2zUiw6Q. Prescription ANORO is used long term to treat COPD, including chronic bronchitis, emphysema, or both. ANORO is not used to relieve sudden symptoms of COPD, won't replace a rescue inhaler, and is not for asthma. IMPORTANT SAFETY INFORMATION • Do not use ANORO to treat sudden symptoms of chronic obstructive pulmonary disease (COPD). Always have a rescue inhaler with you to treat sudden symptoms. • Do not use ANORO if you have a severe allergy to milk proteins or are allergic to any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. • Do not use ANORO if you have asthma. • Do not use ANORO more often than prescribed. • Do not take ANORO with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need to use your rescue inhaler more often than usual, or if your rescue inhaler does not work as well to relieve your symptoms. • ANORO can cause serious side effects, including: − COPD symptoms that get worse over time. If this happens, do not increase your dose of ANORO; instead, call your healthcare provider. − symptoms of using too much of a LABA medicine, including: chest pain; increased blood pressure; fast or irregular heartbeat; headache; tremor; nervousness. − sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; swelling of your face, mouth, and tongue; hives; breathing problems. − effects on heart: increased blood pressure; chest pain; a fast or irregular heartbeat, awareness of heartbeat. − effects on nervous system: tremor; nervousness. − new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. − urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. − changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium. • Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Patient Information, for ANORO at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Sponsored by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed by GSK. ©2019 GSK or licensor. UCVOGM190014 November 2019 Produced in USA.
COPD Treatment | TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol)
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2019 GSK or licensor. FVUBNNR190028 December 2019 Produced in USA.
GSKPro for Healthcare Professionals
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2019 GSK or licensor. FVUBNNR190033 December 2019 Produced in USA.
GSKPro for Healthcare Professionals
Prescribing Info: http://bit.ly/2zUiw6Q. Prescription ANORO is used long term to treat COPD, including chronic bronchitis, emphysema, or both. ANORO is not used to relieve sudden symptoms of COPD, won't replace a rescue inhaler, and is not for asthma. IMPORTANT SAFETY INFORMATION • Do not use ANORO to treat sudden symptoms of chronic obstructive pulmonary disease (COPD). Always have a rescue inhaler with you to treat sudden symptoms. • Do not use ANORO if you have a severe allergy to milk proteins or are allergic to any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. • Do not use ANORO if you have asthma. • Do not use ANORO more often than prescribed. • Do not take ANORO with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need to use your rescue inhaler more often than usual, or if your rescue inhaler does not work as well to relieve your symptoms. • ANORO can cause serious side effects, including: − COPD symptoms that get worse over time. If this happens, do not increase your dose of ANORO; instead, call your healthcare provider. − symptoms of using too much of a LABA medicine, including: chest pain; increased blood pressure; fast or irregular heartbeat; headache; tremor; nervousness. − sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; swelling of your face, mouth, and tongue; hives; breathing problems. − effects on heart: increased blood pressure; chest pain; a fast or irregular heartbeat, awareness of heartbeat. − effects on nervous system: tremor; nervousness. − new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. − urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. − changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium. • Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Patient Information, for ANORO at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Sponsored by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed by GSK. ©2019 GSK or licensor. UCVOGM190015 November 2019 Produced in USA.
COPD Treatment | TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol)
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2019 GSK or licensor. FVUBNNR190032 December 2019 Produced in USA.
GSKPro for Healthcare Professionals
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2019 GSK or licensor. FVUBNNR190035 December 2019 Produced in USA.
COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Once-daily ANORO is a prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing. ANORO is not used to treat sudden COPD symptoms and won't replace a rescue inhaler. ANORO is not for asthma. Important Safety Information •ANORO is only approved for use in COPD. ANORO is NOT approved for use in asthma. •People with asthma who take long-acting beta2-adrenergic agonist (LABA) medicines, such as vilanterol (one of the medicines in ANORO), have an increased risk of death from asthma problems. It is not known if LABA medicines increase the risk of death in people with COPD. •Call your healthcare provider if breathing problems worsen over time while using ANORO. •Get emergency medical care if your breathing worsens quickly or if use of your rescue inhaler does not relieve your breathing problems. •Do not use ANORO to treat sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. •It is not known if ANORO is safe and effective in people with asthma. •Do not use ANORO if you have a severe allergy to milk proteins or any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. •Do not use ANORO more often than prescribed. •Do not take ANORO with other medicines that contain a LABA or an anticholinergic for any reason. Tell your healthcare provider about all the medicines you take and about all of your health conditions. •ANORO can cause serious side effects, including: - sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. - serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. - effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain - effects on nervous system: tremor; nervousness - new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. - urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. - changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium •Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Boxed Warning and Medication Guide, for ANORO ELLIPTA at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Supported by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed to the GSK group of companies. ©2018 GSK group of companies or its licensor. Produced in USA. 1009956R0 October 2018
Blog de cocina, comida sana y recetas saludables | Naturarla
¡Que levanten la mano los amantes del QUESO! ‍♀️‍♂️ ¿Te animas con esta tarta de queso y piña al horno? Con ingredientes 100% naturales, sin aditivos, conservantes, ni colorantes y un toque muy tropical

Moldes y patrones Unicose - Moldes Únicosé
Diamanti-Mobila Moale La Comanda
Гостиная - это центр любой квартиры, который создан для приема гостей, отдыха и общения. Именно она будет отражать ваш вкус, поэтому подойдите к ее оформлению с особой внимательностью и убедитесь, что она на 100% отражает вашу индивидуальность. ‼Возможна оплата в кредит‼ Под заказ любые размеры и цвета Детали в комментариях -------------------------------- str. Decebal, 23 (Jumbo), but.104 068288688 ✨ www.diamante.md
Une Solution Éthique, Résiliente et Abondante | Solution ERA
Depuis quelques jours, vous avez suivi Francis Gendron dans une grande aventure : celle d'un changement de cap complet dans le domaine de l'habitation!! Serez-vous le prochain à entrer dans une nouvelle ère Il ne reste que 48 HEURES compléter votre aventure avec la 4e et dernière vidéo :D Bonne écoute!
P&V Pia & Vyel Wonderplant
School of Advanced Study - University of London
Applications for our programmes close on 31st August 2019. Explore our full- and part-time postgraduate programmes (MA, MRes, LLM, MPhil, and PhD) in a wide range of humanities subjects...
The Wire Hind Jitu Vaidya
New Book Releases, Bestsellers, Author Info and more at Simon & Schuster
It's here! Get your copy of NASH today https://www.simonandschuster.com/books/Nash/Nash-Grier/9781501137211
Sustainable Vegan Accessories - Afroblonde Eco Collection - Shoes, Bags
IED Barcelona - Design School for Your Future
Vị Quảng
Bữa trưa 02 người no căng với 02 Mỳ Quảng + 02 Chè sương sa hạt lựu ♥️ Những hình ảnh feedback đầu tiên của khách hàng trong chương trình #FreeShip của Vị Quảng. Bạn đã thử tính năng Delivery - Giao Hàng Tận Nhà hoàn toàn tự động của Vị Quảng chưa Clip hướng dẫn đặt món tự động : http://bit.ly/2BUzXnC #ViQuang #nhahangViQuang #monngonmienTrung - - - ☎ HOTLINE: 0933 566 669 Vị Quảng 1: 35 Trần Hưng Đạo, HN. ĐT: 024 3943 3962 Vị Quảng 2: 2B ngõ Tràng Tiền, HN. ĐT: 024 3939 2535 Vị Quảng 3: 109 Nguyễn Chí Thanh, HN. ĐT : 024 3845 1999
Yanuk Grill
Google
Temporary Housing - Book furnished apartments online | Homelike
Interior Designer & Artist | San Francisco, CA | vasoperitosid
XAMANI SHOP
➡️ Attention!! Everything is FREE this Summer! Guaranteed Fast & Cheap Shipping! ** Multiple FREE items at checkout ** Don't Miss A Beat..❤️ ➡️ https://xamanishop.com/
Início – Engrandece.com
MAXMAX.cz - tvoříme váš domov | e-shop MAXMAX.cz
CENTO
Wax ลบรอย เคลือบ ผลิตภัณฑ์ดูแลรถยนต์
Love me some Farmasi
Heart rate monitors, activity trackers and bike computers | Polar Canada
Mịn Decor - Chăn Ga Gối
Star Trac Fitness
ITmind education hub
De todo para todos - Solrac
AIMS HK 技術移民專家
Suzuki Auto Tarlac
Electroplanet | Spécialiste Electroménager, Hifi, Multimédia au Maroc
Vous pouvez désormais commander votre Huawei Y9a chez Electroplanet sur ➡️ https://bit.ly/33VJwQB Livraison partout au Maroc Paiement par carte SEULEMENT !
Lumene Polska